135 related articles for article (PubMed ID: 35992548)
1. Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells.
Di J; Jiang B; Shang H; Yang X; Zhang C; Shi X; Chai Y
Contrast Media Mol Imaging; 2022; 2022():1426343. PubMed ID: 35992548
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
Huang S; Chen M; Ding X; Zhang X; Zou X
Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells.
Huang S; Chen M; Shen Y; Shen W; Guo H; Gao Q; Zou X
Cancer Lett; 2012 Feb; 315(2):198-205. PubMed ID: 22104727
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.
Yu S; Li Q; Wang Y; Cui Y; Yu Y; Li W; Liu F; Liu T
Exp Cell Res; 2021 Sep; 406(1):112734. PubMed ID: 34265288
[TBL] [Abstract][Full Text] [Related]
6. ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells.
Fan H; Ou Q; Su Q; Li G; Deng Z; Huang X; Bi J
FEBS Open Bio; 2021 Sep; 11(9):2655-2667. PubMed ID: 34375503
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Zhang Y; Li Q; Yu S; Zhu C; Zhang Z; Cao H; Xu J
Biochem Biophys Res Commun; 2019 Feb; 509(3):753-762. PubMed ID: 30638658
[TBL] [Abstract][Full Text] [Related]
8. The effects and mechanism of α-mangostin on chemosensitivity of gastric cancer cells.
Li RR; Zeng DY
Kaohsiung J Med Sci; 2021 Aug; 37(8):709-717. PubMed ID: 34003591
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
[TBL] [Abstract][Full Text] [Related]
10. BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients.
Wang L; Chunyan Q; Zhou Y; He Q; Ma Y; Ga Y; Wang X
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4064-4070. PubMed ID: 29028095
[TBL] [Abstract][Full Text] [Related]
11. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
Subhash VV; Tan SH; Tan WL; Yeo MS; Xie C; Wong FY; Kiat ZY; Lim R; Yong WP
BMC Cancer; 2015 Jul; 15():550. PubMed ID: 26209226
[TBL] [Abstract][Full Text] [Related]
12. The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
Xin L; Yang WF; Zhang HT; Li YF; Liu C
Br J Cancer; 2018 May; 118(9):1189-1199. PubMed ID: 29576621
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
14. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
15. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin Affects STAT3/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin.
Zhang J; Li Y; Wang JG; Feng JY; Huang GD; Luo CG
Am J Chin Med; 2023; 51(2):445-459. PubMed ID: 36891981
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
Sun B; Han Y; Cai H; Huang H; Xuan Y
Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
[TBL] [Abstract][Full Text] [Related]
18. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
Qi MM; Ge F; Chen XJ; Tang C; Ma J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]